Anne Johnson
Finanzdirektor/CFO bei ATAI LIFE SCIENCES N.V.
Vermögen: 115 536 $ am 31.05.2024
Profil
Ms. Anne Johnson, CPA, is a Chief Financial & Accounting Officer at ATAI Life Sciences NV.
Ms. Johnson was previously employed as a Controller by Aruvant Sciences, Inc., a Corporate Controller by Chimerix, Inc., and a Vice President-Finance by Xanodyne Pharmaceuticals, Inc. She received her undergraduate degree from The University of North Carolina at Wilmington.
Bekannte Unternehmensbeteiligungen
Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
---|---|---|---|---|
ATAI LIFE SCIENCES N.V.
0,04% | 09.04.2024 | 73 590 ( 0,04% ) | 115 536 $ | 31.05.2024 |
Aktive Positionen von Anne Johnson
Unternehmen | Position | Beginn |
---|---|---|
ATAI LIFE SCIENCES N.V. | Finanzdirektor/CFO | 13.10.2023 |
Ehemalige bekannte Positionen von Anne Johnson
Unternehmen | Position | Ende |
---|---|---|
CHIMERIX, INC. | Comptroller/Controller/Auditor | - |
Xanodyne Pharmaceuticals, Inc.
Xanodyne Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Xanodyne Pharmaceuticals, Inc. operates as an integrated specialty pharmaceutical company with both development and commercial capabilities focused on pain management and women's healthcare. It markets a portfolio of prescription pharmaceuticals and a line of prenatal vitamins. The firm's product candidates include XP12B, a tranexamic acid modified release oral tablet for the reduction of menstrual blood loss in women, who suffer from menorrhagia or excessive menstrual bleeding; and XP20B is a combination propoxyphene and acetaminophen modified release oral tablet for the treatment of mild to moderate pain. The company was founded by Gilbert R. Gonzales and Roger Dale Griggs in May 2001 and is headquartered in Newport, KY. | Finanzdirektor/CFO | - |
Aruvant Sciences, Inc.
Aruvant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Aruvant Sciences, Inc. operates as a clinical-stage biopharmaceutical company. The firm develops and commercializes gene therapies for hematological diseases utilizing reduced-intensity conditioning. It's lead candidate ARU-1801, is a modified fetal hemoglobin gene therapy for sickle cell disease and related hemoglobinopathies. The company is headquartered in New York, NY. | Comptroller/Controller/Auditor | - |
Ausbildung von Anne Johnson
The University of North Carolina at Wilmington | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 2 |
---|---|
ATAI LIFE SCIENCES N.V. | Health Technology |
CHIMERIX, INC. | Health Technology |
Private Unternehmen | 2 |
---|---|
Aruvant Sciences, Inc.
Aruvant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Aruvant Sciences, Inc. operates as a clinical-stage biopharmaceutical company. The firm develops and commercializes gene therapies for hematological diseases utilizing reduced-intensity conditioning. It's lead candidate ARU-1801, is a modified fetal hemoglobin gene therapy for sickle cell disease and related hemoglobinopathies. The company is headquartered in New York, NY. | Health Technology |
Xanodyne Pharmaceuticals, Inc.
Xanodyne Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Xanodyne Pharmaceuticals, Inc. operates as an integrated specialty pharmaceutical company with both development and commercial capabilities focused on pain management and women's healthcare. It markets a portfolio of prescription pharmaceuticals and a line of prenatal vitamins. The firm's product candidates include XP12B, a tranexamic acid modified release oral tablet for the reduction of menstrual blood loss in women, who suffer from menorrhagia or excessive menstrual bleeding; and XP20B is a combination propoxyphene and acetaminophen modified release oral tablet for the treatment of mild to moderate pain. The company was founded by Gilbert R. Gonzales and Roger Dale Griggs in May 2001 and is headquartered in Newport, KY. | Health Technology |